Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasms, Plasma Cell × Vinorelbine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 151 Carcinoma, Non-Small-Cell Lung 96 Lung Neoplasms 50 Hodgkin Disease 22 Lymphoma 15 Recurrence 14 Neoplasm Metastasis 14 Triple Negative Breast Neoplasms 12 Neoplasms 12 Prostatic Neoplasms 10 Sarcoma 8 Lymphoma, Non-Hodgkin 8 Uterine Cervical Neoplasms 7 Rhabdomyosarcoma 7 Adenocarcinoma of Lung 7 Lymphoma, Large B-Cell, Diffuse 6 Ovarian Neoplasms 5 Mesothelioma, Malignant 5 Breast Neoplasms, Male 5 Small Cell Lung Carcinoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 NSCLC 4 Brain Neoplasms 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Multiple Myeloma 3 Mesothelioma 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3

Interventions

Dexamethasone 100 Cyclophosphamide 91 Melphalan 85 Bortezomib 63 Peripheral Blood Stem Cell Transplantation 55 Lenalidomide 50 fludarabine phosphate 45 Filgrastim 45 Busulfan 45 Radiotherapy 34 Antilymphocyte Serum 33 Thalidomide 32 Tacrolimus 30 Mycophenolic Acid 26 fludarabine 23 Cyclosporine 23 Methotrexate 21 Etoposide 21 Calcium Dobesilate 21 Prednisone 20 Whole-Body Irradiation 18 Methylprednisolone 18 pomalidomide 16 carfilzomib 16 Granulocyte Colony-Stimulating Factor 15 sargramostim 14 daratumumab 14 Carmustine 13 Rituximab 12 Interferon-alpha 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01220375 2014-04-17

PAV

Insel Gruppe AG, University Hospital Bern

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡